Neuropathological changes underlying clinical heterogeneity in Alzheimer disease
阿尔茨海默病临床异质性背后的神经病理学变化
基本信息
- 批准号:9330754
- 负责人:
- 金额:$ 16.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgingAlzheimer&aposs DiseaseAnatomyAreaArgyrophilic Grain DiseaseAstrocytesAutopsyBiological Neural NetworksBrainBudgetsCaliforniaCharacteristicsClinicalClinical ResearchCohort StudiesCollaborationsCollectionCrutchesDataData AnalysesDementiaDiseaseDisease ProgressionFacultyFundingFunding MechanismsGenetic VariationGoalsGrantHeterogeneityHippocampus (Brain)HumanInternationalInterruptionLeadLesionLongitudinal cohort studyManuscriptsMedical GeneticsMedical StudentsMemoryMentorsMid-Career Clinical Scientist Award (K24)Nerve DegenerationNeurobiologyNeurodegenerative DisordersNeurofibrillary TanglesNeurologistNeuropsychologyOutcomePathologyPatientsPersonsPreparationPreventionPrimary Progressive AphasiaProgram DevelopmentQuality of lifeResearchResearch InfrastructureResearch PersonnelResearch TrainingRiskRisk FactorsRoleSan FranciscoSchemeSenile PlaquesSeveritiesStagingStructureSymptomsTestingTimeTissuesTrainingTraining ProgramsUnited States National Institutes of HealthUniversitiesUniversity resourcesVariantWorkWritingage relatedassociated symptomcareercerebral atrophyclinical effectclinical phenotypecohortdisorder subtypeexperiencegenetic varianthands on researchmid-career facultymultidisciplinaryneuropathologyneuropsychiatric symptomneuropsychiatrynovelnovel markerpatient orientedprogramsprotein TDP-43research studyresidenceskillstau Proteins
项目摘要
ABSTRACT
This is an application for a K24 award for Dr. Lea T. Grinberg, a neuropathologist at the University of
California, San Francisco (UCSF). Dr. Grinberg is an Associate Professor in Residence and co-lead the
UCSF/Memory and Aging Center's Neuropathology Core. She is an established researcher in the patient-
oriented clinical research of dementia. A distinctive hallmark of her research is her direct involvement in
creating, managing and analyzing well-characterized postmortem collections of brains belonging to people at-
risk or already with dementia. Dr. Grinberg proposes to use K24 dedicated time to mentor USCF as well as
international investigators in patient-oriented dementia research. Her mentees will gain hands-on research
experience, expertise in age-related human neuropathology, training in data analysis, manuscript preparation,
and grant writing, as well as career, mentoring. Mentee training will leverage the infrastructure and resources
of the UCSF/Memory and Aging Center Autopsy program, which is part of ongoing longitudinal cohort studies
(P50AG02350 and P01AG019724), and her collaborations with multidisciplinary researchers in the areas of
dementia domestically and worldwide. To increase her mentoring skills, she proposes to participate in the
UCSF Mentor Development Program. Dr. Grinberg intends to conduct K24-supported Alzheimer's disease
research studies that will serve as training vehicles for mentees and expand her research. These studies,
using clinical, genetic and neuropathological data, will be conducted using data from ongoing UCSF/Memory
and Aging Center's NIH-funded cohort studies of persons with Alzheimer's disease(AD) . She will examine the
role of recently described neurodegenerative changes in modifying the clinical phenotype of AD. In summary,
this K24 will enhance Dr. Ginberg's active research program with extensive infrastructure at UCSF to support
her goal to remain a leader in neurodegenerative diseases, especially in the field of neuropathology, and to
develop a program of excellence for training medical students, trainees, and junior faculty in POR related to
age-related neuropathology that is also intended to close the gaps caused by interruption of neuropathology
training for neurologists and neurodegenerative disease training for neuropathologists.
抽象的
这是 Lea T. Grinberg 博士的 K24 奖项申请,她是纽约大学的神经病理学家。
加利福尼亚州、旧金山 (UCSF)。 Grinberg 博士是常驻副教授,并共同领导
加州大学旧金山分校/记忆与衰老中心的神经病理学核心。她是一位在患者领域颇有建树的研究员——
面向痴呆症的临床研究。她的研究的一个显着特点是她直接参与
创建、管理和分析属于以下人员的特征良好的死后大脑集合:
风险或已经患有痴呆症。 Grinberg 博士建议利用 K24 专门时间来指导 USCF 以及
以患者为导向的痴呆症研究的国际研究者。她的学员将获得实践研究
经验、与年龄相关的人类神经病理学方面的专业知识、数据分析培训、手稿准备、
以及资助写作,以及职业指导。学员培训将利用基础设施和资源
加州大学旧金山分校/记忆与衰老中心尸检计划的一部分,该计划是正在进行的纵向队列研究的一部分
(P50AG02350 和 P01AG019724),以及她与以下领域的多学科研究人员的合作
国内和世界范围内的痴呆症。为了提高她的指导技能,她建议参加
加州大学旧金山分校导师发展计划。 Grinberg 博士打算进行 K24 支持的阿尔茨海默病治疗
研究将作为学员的培训工具并扩大她的研究范围。这些研究,
使用临床、遗传和神经病理学数据,将使用正在进行的 UCSF/Memory 的数据进行
和老龄化中心由美国国立卫生研究院 (NIH) 资助的针对阿尔茨海默病 (AD) 患者的队列研究。她将检查
最近描述的神经退行性变化在改变 AD 临床表型中的作用。总之,
这个 K24 将通过 UCSF 广泛的基础设施来加强 Ginberg 博士的积极研究计划,以支持
她的目标是保持神经退行性疾病领域的领导者地位,特别是在神经病理学领域,并
制定一项卓越计划,用于培训医学生、实习生和初级教师 POR 相关领域
与年龄相关的神经病理学,也旨在弥补因神经病理学中断而造成的差距
神经科医生培训和神经病理学家神经退行性疾病培训。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lea Tenenholz Grinberg其他文献
Hypertension may associate with cerebral small vessel disease and infarcts through the pathway of intracranial atherosclerosis
- DOI:
10.1016/j.neurobiolaging.2024.11.001 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:
- 作者:
Marcelo Kenzo Naya Takahashi;Regina Silva Paradela;Lea Tenenholz Grinberg;Renata Elaine Paraizo Leite;Daniela Souza Farias-Itao;Vitor Ribeiro Paes;Maria Eduarda Braga;Michel Satya Naslavsky;Mayana Zatz;Wilson Jacob-Filho;Ricardo Nitrini;Carlos Augusto Pasqualucci;Claudia Kimie Suemoto - 通讯作者:
Claudia Kimie Suemoto
Cause of Death Determined by Full-body Autopsy in Neuropathologically Diagnosed Dementias
通过全身尸检确定神经病理学诊断的痴呆症的死因
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:2.1
- 作者:
Beatriz Astolfi Neves;Paula Villela Nunes;Roberta Diehl Rodriguez;Atmis Medeiros Haidar;Renata Elaine Paraizo Leite;C. Nascimento;Carlos Augusto Pasqualucci;R. Nitrini;W. Jacob;B. Lafer;Lea Tenenholz Grinberg;Claudia Kimie Suemoto - 通讯作者:
Claudia Kimie Suemoto
Lea Tenenholz Grinberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lea Tenenholz Grinberg', 18)}}的其他基金
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression
使用 MRI 对脑铁和蛋白质聚集进行成像,以评估阿尔茨海默病的病理学和进展
- 批准号:
10563181 - 财政年份:2021
- 资助金额:
$ 16.49万 - 项目类别:
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression
使用 MRI 对脑铁和蛋白质聚集进行成像,以评估阿尔茨海默病的病理学和进展
- 批准号:
10331335 - 财政年份:2021
- 资助金额:
$ 16.49万 - 项目类别:
Better memory with literacy acquisition later in life: a randomized controlled trial
晚年读写能力提高记忆力:一项随机对照试验
- 批准号:
10054007 - 财政年份:2020
- 资助金额:
$ 16.49万 - 项目类别:
Better memory with literacy acquisition later in life: a randomized controlled trial
晚年读写能力提高记忆力:一项随机对照试验
- 批准号:
10263225 - 财政年份:2020
- 资助金额:
$ 16.49万 - 项目类别:
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP
阿尔茨海默病和 PSP 睡眠觉醒行为的临床特征和神经病理学基础
- 批准号:
10112791 - 财政年份:2019
- 资助金额:
$ 16.49万 - 项目类别:
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression
将睡眠功能障碍与 AD 进展过程中 Tau 蛋白相关的退化联系起来
- 批准号:
10636812 - 财政年份:2019
- 资助金额:
$ 16.49万 - 项目类别:
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression
将睡眠功能障碍与 AD 进展过程中 Tau 蛋白相关的退化联系起来
- 批准号:
10441484 - 财政年份:2019
- 资助金额:
$ 16.49万 - 项目类别:
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression
将睡眠功能障碍与 AD 进展过程中 Tau 蛋白相关的退化联系起来
- 批准号:
9803439 - 财政年份:2019
- 资助金额:
$ 16.49万 - 项目类别:
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression
将睡眠功能障碍与 AD 进展过程中 Tau 蛋白相关的退化联系起来
- 批准号:
10328419 - 财政年份:2019
- 资助金额:
$ 16.49万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 16.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




